GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Resonance Health Ltd (ASX:RHT) » Definitions » Sale Of Investment

Resonance Health (ASX:RHT) Sale Of Investment : A$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Resonance Health Sale Of Investment?

Resonance Health's sale of investment for the six months ended in Dec. 2024 was A$0.00 Mil. It means Resonance Health gained A$0.00 Mil from selling investments. Resonance Health's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.00 Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2024 ), Resonance Health gained the same money from selling investments in Dec. 2024 (A$0.00 Mil).


Resonance Health Sale Of Investment Historical Data

The historical data trend for Resonance Health's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonance Health Sale Of Investment Chart

Resonance Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Resonance Health Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Resonance Health Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Resonance Health Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Resonance Health's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Resonance Health Business Description

Traded in Other Exchanges
N/A
Address
141-143 Burswood Road, Level 1, Burswood, Perth, WA, AUS, 6100
Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, Cardiac T2, and HepaFat-Scan. It also has several AI-assisted SaMDs including FerriSmart, HepaFat-AI, and LiverSmart. The company's business segments are; Services which derives key revenue, Research and development, Corporate, Clinical Research Organization (CRO), and TrialsWest. Geographically, it generates maximum revenue from the Asia Pacific and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.

Resonance Health Headlines

No Headlines